Results 121 to 130 of about 26,940 (220)

Are we ready to predict progressive disease in juvenile systemic sclerosis? [PDF]

J Scleroderma Relat Disord
Foeldvari I, Klotsche J, Torok KS.
europepmc   +1 more source

Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune‐mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital‐based claims database

Journal of Diabetes Investigation, Volume 17, Issue 8, Page 1310-1321, August 2026.
In this target trial emulation of patients with immune‐mediated inflammatory diseases and type 2 diabetes, SGLT2 inhibitor initiation was not associated with a clear increase in UTI risk versus metformin, including across immunosuppressive therapy strata.
Hiroshi Tsushima, Nobuyuki Yajima, Takashi Nomiyama, Ryoko Sakai, Hisashi Noma, Akira Katagiri, Naoto Tamura   +6 more
wiley   +1 more source

Late-Onset En Coup de Sabre: A Rare Presentation of Linear Scleroderma in an Elderly Woman. [PDF]

Cureus
Jasim N, Farooqui F, Shariff MK, Haider F, Farooqui K.   +4 more
europepmc   +1 more source

Machine Learning Predicts Treatment Response and Prognostic Pathways From Whole‐Blood Transcriptome in Primary Biliary Cholangitis

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background and Aims Prognostic biomarkers that link disease progression and/or responses to therapeutic interventions in patients with primary biliary cholangitis (PBC) remain undefined. In this study, we used a machine learning (ML) approach with whole‐blood transcriptomic data to predict clinical outcomes in response to obeticholic acid (OCA)
Hussain Syed, Ning Sun, Doaa Waly, Varinder Verma, Matthew Smith, David Shapiro, Mary Erickson, Kathy Siminovitch, Mark Swain, Mohammed S. Osman, Andrew L. Mason   +10 more
wiley   +1 more source

Exploring the Role of Skin Microbiota in Autoimmune Skin Diseases from a Bidirectional Mendelian Randomization Perspective. [PDF]

Clin Cosmet Investig Dermatol
Wang J, Wang X, Tao X, Yang Q, Zhang M, Wang Y, Liu S.   +6 more
europepmc   +1 more source

Splenic B Cells Accumulate and Adopt a Pro‐Inflammatory Phenotype to Accelerate Fibrosis in a CCl4‐Induced Liver Fibrosis Model

The FASEB Journal, Volume 40, Issue 14, 31 July 2026.
Splenic B cells accumulate and adopt pro‐inflammatory phenotype via activation of p38 MAPK/NF‐κB pathway, thereby accelerating CCl₄‐induced hepatic fibrosis. ABSTRACT The spleen plays a significant role in hepatic fibrosis progression. B cells are the main splenic lymphocytes, but their specific contributions and underlying mechanisms remain unclear ...
Keping Feng, Qiaoman Fei, Chongyu Zhang, Junqiao Feng, Ke Du, Na Huang, Xurui Zhang, Zhe Zhou, Chengbo Zhang, Shaoying Zhang, Shemin Lu, Yanying Dong, Guangyao Kong   +12 more
wiley   +1 more source

Pruritus associated with systemic sclerosis: a systematic review of treatment-based clinical trials. [PDF]

Rheumatol Int
Mortezaei K, Pasula R, Nursoy M, Syal A, Panayiotou I, Kumari G, Chatzitoffis A, Milutinovic P, Fadugba OO, Derk CT.   +9 more
europepmc   +1 more source

Knowledge and perceptions of medical practitioners on the role of nutrition in systemic sclerosis. [PDF]

J Scleroderma Relat Disord
Efthymiou E, Pardali EC, Gkouvi A, Mitropoulos A, Katsiari CG, Koidou E, Goulis DG, Klonizakis M, Bogdanos DP, Grammatikopoulou MG.   +9 more
europepmc   +1 more source

Development and Validation of Algorithms for Systemic Sclerosis Identification in Electronic Health Record Data. [PDF]

ACR Open Rheumatol
Ozen G, O'Rorke M, Romitti P, Domsic R.
europepmc   +1 more source

Predictor factors of successful treatment response in interstitial lung disease-related systemic sclerosis. [PDF]

J Scleroderma Relat Disord
Danasasmita GW, Wibowo SAK, Rumende CM, Rizka A, Sumariyono S, Ariane A, Shatri H, Singh G.   +7 more
europepmc   +1 more source